Menlo Park, CA – According to filings with the U.S. Securities and Exchange Commission, Deepcell is raising $80,000,095.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Mahdokht Masaeli played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Deepcell
Deepcell offers an AI-powered imaging and microfluidics platform that identifies and isolates viable cells based on morphological distinctions for use in translational research, diagnostic testing, and therapeutics. A novel way to identify and sort cells. Our mission is to enable novel biological insights at the single-cell level for improved diagnosis and treatment of disease. Spun out of Stanford University in 2017, the company has created unique, microfluidics-based technology that uses continuously learning AI to classify cells based on detailed visual features and sort them without inherent bias.

To learn more about Deepcell, visit http://deepcell.com/

Contact:
Mahdokht Masaeli, Chief Executive Officer
617-447-1067
https://www.linkedin.com/in/maddison-mahdokht-masaeli-80a91412/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved